Location History:
- München, DE (2019)
- Munich, DE (2021)
Company Filing History:
Years Active: 2019-2021
Title: Innovations in Cancer Treatment by Jan Friederichs
Introduction
Jan Friederichs is a notable inventor based in Munich, Germany. He has made significant contributions to the field of cancer treatment, particularly focusing on colorectal cancer. With a total of 2 patents, his work emphasizes the importance of genetic markers in predicting cancer prognosis.
Latest Patents
Jan Friederichs' latest patents revolve around methods for treating colorectal cancer using prognostic genetic markers. These inventions relate to prognostic signatures, compositions, and methods for determining the prognosis of cancer in patients. Specifically, they utilize genetic markers to predict the prognosis of colorectal cancer based on genetic signatures. The inventions include methods for predicting the likelihood of long-term survival of cancer patients, determining treatment regimes, and preparing treatment modalities. Additionally, they encompass kits and devices designed to facilitate these methods.
Career Highlights
Jan Friederichs is associated with Pacific Edge Limited, where he continues to advance his research and innovations in cancer treatment. His work has garnered attention for its potential to improve patient outcomes through personalized medicine.
Collaborations
Jan Friederichs has collaborated with notable colleagues such as Hjalmar Nekarda and Bernhard Holzmann. Their combined expertise contributes to the development of innovative solutions in the medical field.
Conclusion
Jan Friederichs stands out as an influential inventor in the realm of cancer treatment, particularly through his innovative approaches to utilizing genetic markers for colorectal cancer prognosis. His contributions are paving the way for advancements in personalized medicine and improved patient care.